← Eichor
Study identifier: NCT05539859 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy and Safety of NeuroEndoscopic Surgery for IntraCerebral Hemorrhage

Condition: Intracerebral Hemorrhage Basal Ganglia  ·  Sponsor: Southwest Hospital, China

PhaseNA
Planned participants560
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

To compare the efficacy and safety of neuroendoscopic hematoma removal and standard conservative treatment for patients with spontaneous supratentorial deep intracerebral hemorrhage.

This description comes directly from the study's public registry record.

Talk to the study team

Rong Hu, MD  ·  8615123917123  ·  huchrong@aliyun.com

Hua Feng, MD  ·  8613708321681  ·  fenghua201818@aliyun.com

Always discuss trial participation with your own doctor first.

Locations (4)

chongqing Emergency Medical CenterChongqing, Chongqing Municipality, ChinaRecruiting
Xiang Yang NO.1 Peoples HospitalHubei, Hubei, ChinaRecruiting
Dazhu County People's HospitalSichuan, Sichuan, ChinaRecruiting
Ganzhou city people's HospitaGanzhou, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05539859